Growth Metrics

Cardio Diagnostics Holdings (CDIO) Gross Profit (2022 - 2025)

Cardio Diagnostics Holdings' Gross Profit history spans 4 years, with the latest figure at -$40880.0 for Q1 2025.

  • For Q1 2025, Gross Profit fell 121.28% year-over-year to -$40880.0; the TTM value through Mar 2025 reached -$169962.0, down 53.99%, while the annual FY2024 figure was -$147556.0, 4.32% down from the prior year.
  • Gross Profit for Q1 2025 was -$40880.0 at Cardio Diagnostics Holdings, down from -$33694.0 in the prior quarter.
  • Across five years, Gross Profit topped out at -$16369.0 in Q3 2022 and bottomed at -$49909.0 in Q2 2024.
  • The 4-year median for Gross Profit is -$29883.0 (2023), against an average of -$32433.5.
  • The largest annual shift saw Gross Profit soared 62.72% in 2024 before it tumbled 121.28% in 2025.
  • A 4-year view of Gross Profit shows it stood at -$26177.0 in 2022, then plummeted by 45.08% to -$37978.0 in 2023, then increased by 11.28% to -$33694.0 in 2024, then dropped by 21.33% to -$40880.0 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Gross Profit are -$40880.0 (Q1 2025), -$33694.0 (Q4 2024), and -$45479.0 (Q3 2024).